Search results (157)
« Back to PublicationsAssessing clinical and cost effectiveness of total versus partial knee replacement (TOPKAT): 10-year follow-up of a multicentre, randomised controlled trial.
Journal article
Beard DJ. et al, (2026), Lancet Rheumatol, 8, e116 - e126
Real-world waitlist randomised controlled trial of gameChange VR to treat severe agoraphobic avoidance in patients with psychosis: a study protocol.
Journal article
Freeman D. et al, (2025), BMJ Open, 15
Effects of empagliflozin on quality of life and healthcare use and costs in chronic kidney disease: a health economic analysis of the EMPA-KIDNEY trial.
Journal article
Zhou J. et al, (2025), EClinicalMedicine, 85
Efficacy of a 6-month supported online programme (Feeling Safer) for the treatment of persecutory delusions: protocol for a randomised controlled trial.
Journal article
Freeman D. et al, (2025), BMJ Open, 15
Association between non-invasive biomarkers and quality of life in Primary Sclerosing Cholangitis.
Journal article
Dai J. et al, (2025), PLoS One, 20
Using QALYs as an Outcome for Assessing Global Prediction Accuracy in Diabetes Simulation Models.
Journal article
Dakin HA. et al, (2025), Med Decis Making, 45, 45 - 59
Perceptions of Cardiovascular Healthcare Professionals Regarding Clinical Trials: A Survey-Based Study from the Middle East.
Journal article
Dakhil ZA. et al, (2025), Glob Heart, 20
Assessing clinical and cost effectiveness of total versus partial knee replacement (TOPKAT): 10-year follow-up of a multicentre, randomised controlled trial
Journal article
Beard DJ. et al, (2025), Lancet Rheumatology
The Impact of Unrelated Future Medical Costs on Economic Evaluation Outcomes for Different Models of Diabetes.
Journal article
Zhao T. et al, (2024), Appl Health Econ Health Policy, 22, 861 - 869
Examining the Impact of Structural Uncertainty Across 10 Type 2 Diabetes Models: Results From the 2022 Mount Hood Challenge.
Journal article
Altunkaya J. et al, (2024), Value Health, 27, 1338 - 1347
Estimating Risk Factor Time Paths Among People with Type 2 Diabetes and QALY Gains from Risk Factor Management.
Journal article
Gao N. et al, (2024), Pharmacoeconomics, 42, 1017 - 1028
The economic burden of cancer, coronary heart disease, dementia, and stroke in England in 2018, with projection to 2050: an evaluation of two cohort studies.
Journal article
Landeiro F. et al, (2024), Lancet Healthy Longev, 5, e514 - e523
Post-trial monitoring of a randomised controlled trial of intensive glycaemic control in type 2 diabetes extended from 10 years to 24 years (UKPDS 91).
Journal article
Adler AI. et al, (2024), Lancet, 404, 145 - 155
Trajectories of clinical characteristics, complications and treatment choices in data-driven subgroups of type 2 diabetes.
Journal article
Li X. et al, (2024), Diabetologia, 67, 1343 - 1355
Associations between BMI and hospital resource use in patients hospitalised for COVID-19 in England: a community-based cohort study.
Journal article
Altunkaya J. et al, (2024), Lancet Diabetes Endocrinol, 12, 462 - 471